|
|
 |
|
Viewing report
|
|
 |
 |
Cardiology, Competitive Strategies, 2002
ADIS, Jan 2002
Cardiology is the largest category of health-care expense in the US - surpassing cancer and infectious diseases by a large margin.
For perspective, the direct and indirect economic costs of cardiovascular diseases and stroke in 2001 are estimated at $298.2 billion in the US, according to the American Heart Association and the National Heart, Lung, and Blood Institute (Nhlbi). Comparable 2001 projections for cancer based on year 2000 National Institutes of Health estimates.
Customers who bought this item also bought
Cardiology Drug Licensing Opportunities, 2002
Nuclear Cardiology Markets 2007
Cardiovascular Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
NeoCardiogenesis- Celebrating The Birth Of Regenerative Cardiology
Stem Cell Research in Cardiology
Cardiovascular Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Diabetic Cardiology
Atherosclerosis: Strategic Audit of Marketplace Activity Issues and Implications
Chinese Markets for Polybutadiene Rubber (BR)
U.S. Interventional Cardiology Markets
Cardiology Information Systems Markets in Europe
Swanton's Cardiology, 6th Edition
|
 |
|
|